Kennedy Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-2,550
Closed -$679K – 628
2022
Q1
$679K Sell
2,550
-11,587
-82% -$2.84M 0.02% 533
2021
Q4
$3.76M Sell
14,137
-258
-2% -$74.8K 0.08% 388
2021
Q3
$4.09M Sell
14,395
-496
-3% -$141K 0.09% 378
2021
Q2
$4.09M Buy
14,891
+1,301
+10% +$354K 0.09% 395
2021
Q1
$3.55M Sell
13,590
-806
-6% -$216K 0.07% 440
2020
Q4
$3.68M Sell
14,396
-451
-3% -$112K 0.08% 412
2020
Q3
$3.51M Sell
14,847
-338
-2% -$71.2K 0.1% 379
2020
Q2
$2.95M Buy
15,185
+94
+0.6% +$18K 0.09% 428
2020
Q1
$2.5M Buy
+15,091
New +$2.76M 0.09% 401

Other funds holding PODD

Kennedy Capital Management's PODD Position: Q2 2022 in Review

Kennedy Capital Management sold out of Insulet (PODD) in Q2 2022, closing a stake of 2,550 shares — an estimated $679K sold.

Kennedy Capital Management first reported a position in PODD in Q1 2020 and held it in 9 quarters. The position peaked at $4.09M in Q3 2021. 450 funds tracked by Wall St. Rank hold PODD as of Q2 2022.

  • Kennedy Capital Management reported no remaining Insulet position as of Q2 2022 after selling out during the quarter.
  • Kennedy Capital Management sold 2,550 Insulet shares in Q2 2022, an estimated $679K.
  • Kennedy Capital Management first reported a position in Insulet in Q1 2020 and held it in 9 quarters.
  • Kennedy Capital Management's Insulet position peaked at $4.09M in Q3 2021.
  • 450 funds tracked by Wall St. Rank held Insulet as of Q2 2022.

Based on Kennedy Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.